| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Zinc homeostasis 0.912495624781239 3.436719352578072 0.0005888053607463 0.2906275873244449 0.0167233307096531 2 Q8TAD4 1 |
| Inclusion body myositis 0.9093454672733634 3.422411050669378 0.0006206840236646 0.3036975317768883 0.0167233307096531 2 P05067 1 |
| Eicosanoid synthesis 0.895344767238362 3.358504343828509 0.0007836548957882 0.3668512626638339 0.0168499368288583 2 P09960 1 |
| Glycosaminoglycan degradation 0.9477742726954066 3.091643534465751 0.0019905172298737 0.6870237748356267 0.0236830927554367 6 P15586,P54802,P08236,P16278,P06865 5 |
| Kennedy pathway from sphingolipids 0.8809106830122604 2.998561656619383 0.0027125726443557 0.7947606890066301 0.0261064570048451 4 O95470,P35790,Q9UG56 3 |
| Degradation pathway of sphingolipids including diseases 0.9166160243073892 2.955984067613195 0.0031167319044564 0.8379567872416315 0.0267213926514431 6 P17900,P06865,P16278,P06280 4 |
| Metabolism of spingolipids in er and golgi apparatus 0.8763139453398714 2.876821940747221 0.0040170219543409 0.9043098789246 0.0320578877494147 5 O95470,Q16739,Q10472,Q06136 4 |
| Familial hyperlipidemia type 4 0.7917395869793489 2.868857615030727 0.004119572026199 0.9098852237467606 0.0320578877494147 2 Q9UBV2 1 |
| Sphingolipid metabolism in senescence 0.8542273935611457 2.868511270923982 0.0041240850449504 0.910122990931702 0.0320578877494147 10 Q13510,O15121,P04062,P16278,Q16739,Q06136,Q96G23 7 |
| Proteoglycan biosynthesis 0.8441092210940265 2.830273588133111 0.0046508215534701 0.9339771093981984 0.034761909816322 4 Q8TB61,Q8NCH0 2 |
| Vitamin d metabolism 0.7944677871148467 2.738088815352997 0.0061797384254635 0.9730552207523578 0.0409407670686963 3 P38435,P04062 2 |
| Glycerolipids and glycerophospholipids 0.8181002987563842 2.7091829578899236 0.0067449134076202 0.980660505190093 0.0427422230069851 4 Q9HCL2,Q9UG56 2 |
| Iron metabolism in placenta 0.7507875393769688 2.6666934366432407 0.0076601510163991 0.988701219829148 0.0470091372901127 2 P02786 1 |
| Sphingolipid metabolism overview 0.8221540490420801 2.6142610038626177 0.0089420696895803 0.9946820906727328 0.0516664644735412 8 Q13510,O15121,O95470,Q16739,Q06136,Q96G23 6 |
| Sphingolipid metabolism integrated pathway 0.8221540490420801 2.6142610038626177 0.0089420696895803 0.9946820906727328 0.0516664644735412 8 Q13510,O15121,O95470,Q16739,Q06136,Q96G23 6 |
| Liver x receptor pathway 0.7388869443472172 2.6069820673266317 0.0091344144010687 0.995251064392429 0.0516664644735412 2 P49327 1 |
| Nanomaterial induced apoptosis 0.7668067226890765 2.6039113534782934 0.0092166591856746 0.9954754063522764 0.0516664644735412 3 P49327,Q9NR28 2 |
| Ferroptosis 0.6460659798229822 2.5666532659182533 0.0102685234429622 0.9975642430875764 0.0554310108078425 20 P09601,Q9Y277,P16435,P45880,Q9NZ45,P37268,P02786,Q96QD8 8 |
| Autophagy 0.7864500096139067 2.5593562163248627 0.0104866225832613 0.997857930555827 0.0560889996884531 4 Q7Z3C6 1 |
| Sphingolipid pathway 0.786830369122781 2.489818979590227 0.0127808172800978 0.9994464964757604 0.062615264489891 9 Q13510,P04062,O95470,Q16739,Q06136,Q96G23 6 |
| Statin inhibition of cholesterol production 0.7674255691768846 2.4679696321874625 0.0135881846754319 0.9996564666810408 0.0654703443452632 4 Q14534,Q8WTV0,P37268 3 |
| Alzheimers disease 0.4323113737143859 2.4060288989670005 0.0161269889289614 0.9999235346514416 0.0740317680754688 76 Q92542,Q9UJX6,P12236,P21796,P48556,P16615,P45880,P60900,P28072,Q9NQC3,P28070,Q9Y277,P05067,P49327,Q8NE86,O43242,Q99570,P49721,P49841,P49720,O95197,P20618 22 |
| Alzheimers disease and mirna effects 0.4308388497729543 2.401042558270094 0.0163484350223814 0.9999329389321254 0.0744620126410031 77 Q92542,P28074,Q9UJX6,P12236,P21796,P48556,P16615,P45880,P60900,P28072,Q9NQC3,P28070,O14654,Q9Y277,O00487,P05067,P49327,Q8NE86,O43242,Q99570,P49721,P49841,P49720,O95197,P04350,P67870,Q96IX5,P20618 28 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.7114845938375358 2.3288183797558406 0.0198686892940498 0.9999917067375688 0.0851723960178753 3 P08195,Q15758 2 |
| Copper homeostasis 0.7399637469239255 2.2372454992467032 0.0252702991117061 0.9999996692587436 0.1016040302215497 5 O75880,P05067,Q04656 3 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6859244777199727 2.1986429154336733 0.0279033229175724 0.9999999316695384 0.1091787735633875 3 P49841 1 |
| Mitochondrial complex iv assembly 0.6843616115451765 2.1865824084720407 0.0287730227106433 0.9999999594501064 0.1105676238829211 13 Q7KZN9,Q8N8Q8,P14406,Q9Y2R0,P13073,Q9P0S2 6 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7379592939621171 2.1663530053632334 0.0302842221579267 0.999999983642336 0.1124566975673329 7 Q15125,Q16850,Q15392 3 |
| Il10 antiinflammatory signaling pathway 0.7041333201126879 2.1566501426886413 0.031032934434763 0.9999999895730736 0.1137874262607979 4 P09601 1 |
| Allograft rejection 0.7106795331423947 2.106944348888114 0.0351224037714548 0.9999999991142612 0.1241943732948335 9 Q9BY49,P10321,P04439 3 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.6879159369527178 2.075076949115146 0.0379794037058942 0.9999999998427872 0.1294797399051871 4 Q13155,Q14145,P09601 3 |
| Glycerophospholipid biosynthetic pathway 0.718439073512835 2.0699409219602933 0.0384578771723389 0.9999999998823677 0.1294797399051871 7 O95674,Q9HCL2,Q9BTU6,P48651 4 |
| 15q112 copy number variation syndrome 0.6851138353765354 2.0609086935883676 0.0393117517522103 0.9999999999299216 0.1294797399051871 4 Q06787,Q9BSJ2,Q96CW5 3 |
| Metapathway biotransformation phase i and ii 0.5678742943395126 2.041403558945704 0.0412107310041185 0.9999999999778892 0.1309320257303629 20 Q7LGA3,Q8NCH0,P78417,P21964,Q16850,Q99735 6 |
| Wntbetacatenin signaling pathway in leukemia 0.6806360971525647 2.038223134187373 0.041527622925513 0.9999999999817648 0.1309320257303629 4 P49841 1 |
| Oxidation by cytochrome p450 0.6995290660508151 2.038020343801873 0.041547898387851 0.9999999999819884 0.1309320257303629 5 O43169 1 |
| Apoptosis modulation by hsp70 0.649390142687262 2.0092155011845416 0.0445142844904133 0.999999999997044 0.1380416375420798 3 P49327 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6713827428367818 1.991169345619196 0.0464622727404011 0.9999999999991004 0.1396263144724426 4 Q9BXK5,P49841 2 |
| 7oxoc and 7betahc pathways 0.6865315906695966 1.982051035414839 0.0474735289532295 0.9999999999995156 0.1404305621347128 9 O15118,P61916 2 |
| Triacylglyceride synthesis 0.6829011913104381 1.9548356439256251 0.0506024725791698 0.9999999999999288 0.1453263128751527 5 Q99943,Q9HCL2,O15228,Q9NUQ2 4 |
| Cytosine methylation 0.6695170065035971 1.887359587661595 0.0591119767796988 0.9999999999999996 0.1610387030960953 5 O75874 1 |
| Camkk2 pathway 0.6588379332991912 1.8758445851163572 0.0606766237666722 1.0 0.1621938845300626 10 Q13501,P09601,Q9Y3D6,Q14012 4 |
| Estrogen receptor pathway 0.6181042473779179 1.8439440764695685 0.0651912906645066 1.0 0.1686935345664049 3 Q9HCL2 1 |
| Photodynamic therapyinduced ap1 survival signaling 0.6318213886618764 1.787432519041755 0.073867609649489 1.0 0.1848275383075197 4 P49327,P07900 2 |
| Mthfr deficiency 0.6565931146939483 1.729391292529257 0.0837390873740857 1.0 0.2034161997462166 6 P21964 1 |
| Purinergic signaling 0.5924369747899172 1.7063723318251875 0.0879387786498862 1.0 0.2101160162003428 3 P08754,P63096 2 |
| Nonalcoholic fatty liver disease 0.4168937469401818 1.6756560447048363 0.093805584223656 1.0 0.2200859228041579 48 O14949,Q9UDW1,P49841,O75380,Q9P0J0,Q86Y39,O96000,O95168,P14406,O75438,O43676,P60953,P31930,P49327,P21912,P13073,P00403,Q96J02 18 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.6248002954836165 1.658741938933586 0.0971678045102062 1.0 0.2239084190887361 5 O00584 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4897761754842611 1.6191930576038902 0.1054057312700216 1.0 0.2400450833219633 22 P37268,Q14534,Q15800,O75845,Q9UBM7,P49327,Q15125,Q15392,Q16850,P35610,P14324,Q15738 12 |
| Proteasome degradation 0.4226879169227153 1.6124608664213953 0.1068616890889238 1.0 0.2424138705791539 41 P28070,P49721,O43242,P49720,P60900,P10321,P01889,P28072,P04439,P20618 10 |
| Nrf2 pathway 0.4928621390590326 1.5731239719607837 0.1156901152009539 1.0 0.2564537534682743 21 Q13501,Q9H2J7,P09601,Q14914,Q99735,Q8N1S5 6 |
| Adipogenesis 0.5797681332302782 1.517513730461916 0.1291370295347498 1.0 0.2747696650319677 12 P43490,Q9NZ45 2 |
| Genes related to primary cilium development based on crispr 0.5947112427343999 1.4929546837423393 0.1354490494209872 1.0 0.2840532223468905 9 Q10713,Q9Y496,Q8NCM8 3 |
| Mitochondrial complex iii assembly 0.5804844365888777 1.4824810220110791 0.1382123496136624 1.0 0.28506196534523 11 O14949,Q6DKK2 2 |
| Hedgehog signaling pathway wp4249 0.5445519805956993 1.4455935197548049 0.148291245303592 1.0 0.3033466526736637 3 Q9Y496 1 |
| Amyotrophic lateral sclerosis als 0.5851992762324288 1.412416757456011 0.157827285172484 1.0 0.3150601871252762 8 Q9BUN8 1 |
| Hepatitis b infection 0.5008346551898153 1.4022816626697714 0.1608311540303864 1.0 0.3178459755922551 17 P62993,Q9Y277,Q15904,Q7Z434,Q16531 5 |
| Endothelin pathways 0.5873456774860459 1.3981762690067931 0.1620601411870623 1.0 0.3191042072753995 7 P16615,P42892 2 |
| Heart development 0.5085754287714386 1.366479027271278 0.1717886592290387 1.0 0.3349591582960856 2 P35222 1 |
| P53 transcriptional gene network 0.5710689129141752 1.3366004186243825 0.1813531023190462 1.0 0.3489401275643695 8 P04066 1 |
| Electron transport chain oxphos system in mitochondria 0.364688298197992 1.2825179694439583 0.199661005473249 1.0 0.3791608019247694 53 O75380,P03886,O96000,P14406,O43676,O75438,P13073,P12236,P56385,O75880,O75964,Q9UDW1,Q7KZN9,P24539,O14949,O95168,P31930,P21912,P00403 19 |
| Cholesterol biosynthesis pathway 0.5344367872790992 1.253569252662455 0.2099986128906876 1.0 0.3935046961648175 12 Q15800,O75845,Q16850,P14324,Q14534 5 |
| Notch signaling 0.5634948387371188 1.2519471176893937 0.2105891341396621 1.0 0.3935046961648175 6 Q92542 1 |
| Neural crest differentiation 0.550314417005419 1.2248157640669923 0.2206446440572329 1.0 0.4083677063027517 8 Q04721,P49841,Q9NR77 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.507361456371928 1.2136201957117108 0.2248927913816825 1.0 0.4136040926672583 14 P55209,O75844,O60725 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.5338794980310838 1.1822722231659406 0.2370977033722616 1.0 0.4319623783313392 5 P09601 1 |
| Influence of laminopathies on wnt signaling 0.5215221839040608 1.1454731574102592 0.2520132085829369 1.0 0.45207292493493 11 O60725 1 |
| Heme biosynthesis 0.5080336930036711 1.1291187733290158 0.2588477328274587 1.0 0.4600860617024648 4 P08397,P22830 2 |
| Gaba metabolism aka ghb 0.4641232061603078 1.1133686267855862 0.2655501434607099 1.0 0.4677093865435243 2 P51649 1 |
| Nrf2are regulation 0.5315751823108558 1.1034517920310722 0.2698310156912282 1.0 0.4677093865435243 7 Q13155,Q14145,P49841,P09601 4 |
| Network map of sarscov2 signaling pathway 0.419047799254817 1.0732814614784805 0.2831448503915028 1.0 0.4770908895325033 22 Q08380,Q7Z434,P31350,Q9UBR2,Q96J02 5 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3930332364303476 1.0617990795494292 0.2883269077680483 1.0 0.4830304230711845 26 Q9HCL2,Q8WTV0,Q9UKV5,Q16850,P37268,Q9NR31,Q9Y6B6,P14324,Q14534 9 |
| Ketogenesis and ketolysis 0.5102760058205053 1.0575212337297937 0.2902737690698682 1.0 0.4848985884462269 5 P23786,O43772,P53985 3 |
| Mirna biogenesis 0.4719887955182089 1.0447320782761236 0.296146814548345 1.0 0.4887275404602521 3 Q9HAV4,Q9UPY3 2 |
| Interactions between loxl4 and oxidative stress pathway 0.4705882352941194 1.0370009564518463 0.2997354114097106 1.0 0.4917865965503947 3 Q16543,Q9BQ95 2 |
| P38 mapk signaling pathway 0.5179238295994294 1.015273455080819 0.3099754942421566 1.0 0.5033863875854522 6 P62993 1 |
| Ciliopathies 0.4828362766178732 1.0024561859699157 0.3161233174370275 1.0 0.5091157294635 13 Q10713,Q99570,Q8NCM8,O43924 4 |
| Cytosolic dnasensing pathway 0.5002886463729735 0.9746067145687182 0.3297553816653797 1.0 0.526065045410939 9 Q9BUI4,Q7Z434 2 |
| Spinal cord injury 0.466821322528939 0.9607849281008094 0.336660318346849 1.0 0.5319050558162953 14 O94813,P60953,Q08722,P11802,P08670,Q9NQC3 6 |
| Genes controlling nephrogenesis 0.5066749620642987 0.9570520112103872 0.338541003626938 1.0 0.533430824633797 6 O94813 1 |
| G1 to s cell cycle control 0.3926483355278833 0.9538015561235088 0.3401841015752103 1.0 0.5345750167610448 24 P33993,Q00534,P49642,P06493,P35244,Q99640,Q9Y619,P11802 8 |
| Praderwilli and angelman syndrome 0.4885816575425593 0.9432776029511832 0.3455389287576875 1.0 0.5386342124752188 5 P11802,Q15154,Q00534 3 |
| Familial partial lipodystrophy fpld 0.5005529616973586 0.939547272122446 0.3474498334988669 1.0 0.5401686744795718 7 O60725 1 |
| Type ii diabetes mellitus 0.4287714385719284 0.91298836802984 0.3612486592441062 1.0 0.5542314956297735 2 P42345 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.4277213860693034 0.9070824764281608 0.3643631840551748 1.0 0.5575426149715669 2 P28288 1 |
| Folatealcohol and cancer pathway hypotheses 0.425271263563178 0.8933169932187572 0.3716874402834806 1.0 0.5657800983949588 2 Q99707 1 |
| Metastatic brain tumor 0.4325689899613686 0.828808093706218 0.4072130076051909 1.0 0.6038952258359772 3 P60953 1 |
| Ebola virus infection in host 0.347196947111043 0.8214826632218745 0.4113713952275657 1.0 0.605630109640583 34 O15118,P10321,P04439,P61916 4 |
| Complement system in neuronal development and plasticity 0.4749224123599526 0.819266696867244 0.4126342689529454 1.0 0.605959140553066 8 Q5KU26,Q9NR28 2 |
| Vitamin d receptor pathway 0.4632049512950218 0.7903489667534689 0.4293239971990079 1.0 0.6242229643992123 10 Q8IWT6,Q96KA5,Q5VV42,Q92604 4 |
| Progeriaassociated lipodystrophy 0.4599017261130267 0.7720986455803407 0.4400560043610719 1.0 0.6350313132240222 10 O60725 1 |
| Fragile x syndrome 0.337233850237894 0.727293624081767 0.4670461031290167 1.0 0.6608929080684873 35 Q9NZ01,P50416,Q14012,P53985,P05067,P53680,P10644,P51648 8 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.4389545501398902 0.695777338908759 0.486568282935595 1.0 0.6770062897156576 12 P05067 1 |
| Rala downstream regulated genes 0.4330380650024499 0.6570262212849831 0.5111640564110784 1.0 0.699550809595443 5 P60953,P11233 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4414624425160505 0.6439062083929931 0.5196362556683132 1.0 0.7068877561133707 8 Q9NR77,P07196 2 |
| Mitochondrial complex i assembly model oxphos system 0.3280252089093465 0.6430946458601107 0.5201626884607822 1.0 0.7068877561133707 30 Q9BUB7,Q9P0J0,P03886,Q9NPL8,O96000,O95168,O43676 7 |
| Nuclear receptors metapathway 0.3183963575042224 0.5981259580307323 0.5497558909912907 1.0 0.7367992745929253 46 Q13501,P23786,P50416,Q9H2J7,P09601,Q14914,Q9HCL2,P30041,Q99735,Q8N1S5 10 |
| Mitochondrial immune response to sarscov2 0.4216851800261655 0.5530032392939378 0.5802611920510536 1.0 0.7585028586676329 9 Q86UT6,Q7Z434 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.39263947816513 0.5271796631807769 0.5980688298744521 1.0 0.7748313951484568 4 P07900 1 |
| Notch signaling pathway 0.4063333923805358 0.4974943791311974 0.6188404656826676 1.0 0.7877379726921292 11 Q04721,Q92542,Q96J02 3 |
| Endochondral ossification with skeletal dysplasias 0.409066747671805 0.4721908980856936 0.6367905358835513 1.0 0.8041735895432781 6 Q96QD8 1 |
| Endochondral ossification 0.409066747671805 0.4721908980856936 0.6367905358835513 1.0 0.8041735895432781 6 Q96QD8 1 |
| Small cell lung cancer 0.4072905713284351 0.463999344681814 0.642648215137676 1.0 0.8074653220372093 6 P63208,Q00534,P06756,P11802,P05556 5 |
| Aryl hydrocarbon receptor pathway wp2873 0.3767941549941466 0.4516435596405656 0.6515257841206608 1.0 0.8156737317002221 4 P07900 1 |
| Nephrotic syndrome 0.3939533482570879 0.4458710909551748 0.655690365691961 1.0 0.8168108615350711 12 Q14108 1 |
| Sulfation biotransformation reaction 0.3574929971988816 0.442723248603846 0.657965924332991 1.0 0.8178979400557221 3 P00390,P11413 2 |
| Glycosylation and related congenital defects 0.3950478532091247 0.4196326220862005 0.6747538532740989 1.0 0.8281715714922098 9 Q2TAA5,P15291 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.368108706266145 0.4057881324557776 0.6848982792176344 1.0 0.8336027072732376 15 Q9BY49,P23786,P40939,O43772 4 |
| T cell receptor and costimulatory signaling 0.3466306035205476 0.3920941372433861 0.6949886592096597 1.0 0.8374713197621989 3 P49841 1 |
| 3q29 copy number variation syndrome 0.3860612166188021 0.3764983601854733 0.706546434344991 1.0 0.8434187943698941 9 Q8NCM8,P02786 2 |
| Neural crest cell migration in cancer 0.3835286124905364 0.358305022596746 0.7201150598106842 1.0 0.8531271293976977 7 Q99523 1 |
| Vitamin b12 disorders 0.3350840336134475 0.3404113338157075 0.7335467846614581 1.0 0.8553155509152601 3 Q99707,Q96EY8 2 |
| Oxysterols derived from cholesterol 0.377972127780645 0.3339389543968492 0.7384256240634239 1.0 0.8592857062454614 7 Q9UBM7,Q15125 2 |
| Oxidative phosphorylation 0.2924655074488761 0.3160810561436254 0.751940985207455 1.0 0.865244275286112 32 P56385,Q86Y39,P03886,O95168,O96000,Q15904,O75438,O75964,O75787,P24539 10 |
| Intraflagellar transport proteins binding to dynein 0.3736733379713258 0.3154093699464054 0.7524508534649379 1.0 0.865244275286112 7 Q8NCM8 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3454800280308328 0.2578547137833496 0.7965190363475296 1.0 0.9006643541962014 5 P42345,P49841,P05556,P06730 4 |
| Physicochemical features and toxicityassociated pathways 0.3423570302042166 0.2329652614292567 0.8157883809921955 1.0 0.907792135130719 14 P62993,P07196,Q14012 3 |
| Netrinunc5b signaling pathway 0.348493823358935 0.2185037402150821 0.827036644453377 1.0 0.907792135130719 12 Q92859 1 |
| Striated muscle contraction pathway 0.3021708683473409 0.207609195145042 0.8355341241126781 1.0 0.9139144359431358 3 P08670,O43707 2 |
| Nucleotide excision repair 0.2991748209127386 0.199423791632415 0.8419312512090484 1.0 0.9180336822121384 23 P18074,P35244,P41208,Q9Y2S7,Q9NR33,Q16531 6 |
| Ccl18 signaling pathway 0.3418279401970377 0.1829715822402643 0.854820316261766 1.0 0.9228893414455732 9 P00403,Q86UE4,P07196 3 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.3022767075306521 0.1508170191691316 0.8801200604776978 1.0 0.941486229832106 4 P61201,P18031,P06730 3 |
| Biomarkers for pyrimidine metabolism disorders 0.3225910444350842 0.1154399924139913 0.908096381471546 1.0 0.967861408405688 8 Q7LG56 1 |
| Il18 signaling pathway 0.2665025901731999 0.1116764994488236 0.9110799134711852 1.0 0.9692693240031042 50 Q9Y6M7,P50416,P09601,Q9NQX7,Q8TCT8,P40939,Q9NZJ7,O96008,Q9HC07 9 |
| Mecp2 and associated rett syndrome 0.2979610383501503 0.0997394753950759 0.9205511599490744 1.0 0.9775616142992904 18 Q03518,P52597,Q99640,P35637,Q00013 5 |
| Apoptosis 0.314639856704425 0.0893006997646344 0.9288429379614404 1.0 0.9845735142391268 8 P49327,Q9NR28 2 |
| Fluoropyrimidine activity 0.3167460963081707 0.0841739512128069 0.932918128592841 1.0 0.987098491777906 12 Q92820,P31350 2 |
| Pyrimidine metabolism and related diseases 0.309839758780887 0.0742742158176322 0.9407921931461852 1.0 0.9936265373264964 8 Q7LG56 1 |
| Gaba receptor signaling 0.3028797313028448 0.070037222062614 0.944164033441746 1.0 0.9953845054186944 6 P53680 1 |
| Tryptophan metabolism 0.3018277679481134 0.0491914409774826 0.9607667321211262 1.0 1.0 14 P51648,P40939 2 |
| Fatty acid transporters 0.2799579537491243 0.048261203758905 0.961508073419979 1.0 1.0 5 Q9UKU0,Q6P1M0,O95573,O60488 4 |
| Omega9 fatty acid synthesis 0.2799579537491216 0.0482612037588983 0.9615080734199845 1.0 1.0 5 O00767,P49327,O95573,O60488 4 |
| Apoptosis modulation and signaling 0.300781170383201 0.0345497126140435 0.972438801054926 1.0 1.0 10 Q07820,P49327,Q9NR28 3 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.2704975473020332 0.0266769824763466 0.9787173719207114 1.0 1.0 5 P35222,P49841,Q13546,P63000 4 |
| Angiopoietinlike protein 8 regulatory pathway 0.2729929957364742 0.0237877179437632 0.9810219369397876 1.0 1.0 22 Q99570,O14654,O75955,P49841,P51812,O00767,Q14254,P49327,P18031 9 |
| Novel intracellular components of rigilike receptor rlr pathway 0.2894900895366932 0.0171238898645633 0.9863377803494282 1.0 1.0 8 Q7Z434 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.2895752895752784 0.0018010605793026 0.9985629623476188 1.0 1.0 10 P78406,Q92769,Q7Z434,P52948,P42224,P35613,Q13546,Q14258,O43747 9 |
|
|
